CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- 8-K Event Executive or director change · Shareholder vote results
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Director sold 4,567 shares at $0.36 ($1,653)
- 4 Grant or award SVP, Chief Medical Officer acquired 200,000 shares (grant or award)
- 4 Grant or award SVP, Chief Accounting Officer acquired 150,000 shares (grant or award)
- 8-K Event Agreement ended · Delisting notice
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- EFFECT Other Notice of Effectiveness
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
Page 15 of 45 · 886 filings